IMMvention Therapeutix, Inc., a Durham early-stage biotechnology company focused on discovering and developing human ...

Novo Nordisk’s 56-acre expansion project is expected to wrap up by 2029. Novo Nordisk also has a facility in Durham, where it plans to hire more than 100 additional employees by the end of 2027 ...

North Carolina achieved a record-breaking year for life sciences investments in 2024. Twenty-five companies announced ...

Kuykendall is leading the expansion project for Novo Nordisk, the healthcare giant that already has three manufacturing facilities in the Triangle -- one in Durham and two in Clayton. The ...

DURHAM, NC, USA I2, 2025 I IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human ...

DURHAM, N.C., Jan. 22 ... today announced a strategic collaboration and license agreement with Novo Nordisk A/S to co-develop oral therapies for sickle cell disease (SCD) and other chronic ...

IMMvention Therapeutix, Inc ., an early-stage biotechnology company focused on discovering and developing human therapeutics, today announced a strategic collaboration and license agreement with Novo ...